Skip to content

Effect of Ayurvedic Formulations Bpgrit with Mukta vati Extra Power in the Management of Hypertension

A Clinical Study to Evaluate the Antihypertensive Effect of Ayurvedic Formulations Bpgrit with Mukta vati Extra Power in the Management of Hypertension: Prospective, open label, single arm study - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113534
Enrollment
92
Registered
2026-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Nil: Nil

Sponsors

Patanjali Research Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Blood pressure ranging between 130/80 to 180/120 mmHg The subject is able and willing to provide consent

Exclusion criteria

Exclusion criteria: Alcohol-associated liver disease (ALD) engage in heavy drinking about 4 or more drinks per day or 8 or more drinks per week for women and 5 or more drinks per day or 15 or more drinks per week for men and other causes of liver disease. Patients with uncontrolled diabetes mellitus HbA1C more tha equal to 7%, hepatic or renal failure. Patients with expected pregnancy or breastfeeding. History of angina pectoris, myocardial infarction or stroke were excluded from the study. Patient not willing to give written informed consent.

Design outcomes

Primary

MeasureTime frame
Changes in Systolic Blood Pressure and Diastolic Blood pressureTimepoint: Baseline to Day 90 on each 7th Day

Secondary

MeasureTime frame
Change in the MINICHALTimepoint: Baseline to Day 90

Countries

India

Contacts

Public ContactDr Ajay Singh

Patanjali Ayurved Hospital

drajaysingh82@gmail.com9039402300

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026